The Centers for Medicare & Medicaid Services and the Department of Health and Human Services Office of Inspector General recently issued a 627-page final rule that will affect fair market value (FMV) and commercial reasonableness (CR) as we know it. The final rule serves to modernize and clarify Stark Law regulations. Many of the changes are aimed at eliminating regulatory restrictions that could deter or even potentially eliminate some novel arrangements, as the industry continues its move toward a value-based healthcare system. The regulations take effect on January 19, 2021, with one exception. An extension has been granted until January 1, 2022, for compliance related to certain changes required in group practice compensation methodologies.
PYA Principals Angie Caldwell and Lyle Oelrich presented a complimentary one-hour webinar explaining the contents of the Stark Final Rule, how to prepare for it, and what happens once it takes effect. They:
- Provided key takeaways surrounding the Big 3 — FMV, Commercial Reasonableness, and Value or Volume Standard (V/V).
- Debunked FMV/CR myths.
- Provided practical guidance and application of the Big 3.
- Shared an overview of the value-based care revisions.
- Gave key guidance surrounding group practice updates.
- Explored other primary conclusions.
The webinar took place Wednesday, December 16, 2020. Qualified attendees earned 1 CPE credit in specialized knowledge.
Resources: Slides
If you need further guidance related to Stark Law changes or need assistance with FMV, CR, or V/V, contact a PYA executive below at (800) 270-9629.
